BFPW
CRBP icon

BOK Financial Private Wealth’s Corbus Pharmaceuticals CRBP Stock Holding History

BOK Financial Private Wealth’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-500
Closed -$102K – 140
2016
Q3 		$102K Buy
+500
New +$62.2K 0.02% 142

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BOK Financial Private Wealth's CRBP Position: Q4 2016 in Review

BOK Financial Private Wealth sold out of Corbus Pharmaceuticals (CRBP) in Q4 2016, closing a stake of 500 shares — an estimated $102K sold.

BOK Financial Private Wealth first reported a position in CRBP in Q3 2016 and held it in 1 quarter. The position peaked at $102K in Q3 2016. 49 funds tracked by Wall St. Rank hold CRBP as of Q4 2016.

  • BOK Financial Private Wealth reported no remaining Corbus Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • BOK Financial Private Wealth sold 500 Corbus Pharmaceuticals shares in Q4 2016, an estimated $102K.
  • BOK Financial Private Wealth first reported a position in Corbus Pharmaceuticals in Q3 2016 and held it in 1 quarter.
  • BOK Financial Private Wealth's Corbus Pharmaceuticals position peaked at $102K in Q3 2016.
  • 49 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2016.

Based on BOK Financial Private Wealth's 13F filing for Q4 2016, filed 8 Feb 2017.